26 June 2020>: Clinical Research
Hepatitis B Surface Antigen (HBsAg) Kinetics in Chronic Hepatitis B Patients during Peginterferon Treatment
Kaifa Wang 1AEG , Guangyu Huang 2BCF* , Yagang Chen 2DF , Yuming Wang 34BFDOI: 10.12659/MSM.921487
Med Sci Monit 2020; 26:e921487
Table 1 Basic information of functionally cured patients.
ID | Gender | Age (years) | Baseline HBsAg (IU/mL) | Treatment duration (days) |
---|---|---|---|---|
467029 | Male | 53 | 3.4 | 88 |
492622 | Male | 40 | 0.1 | 49 |
24386 | Male | 37 | 1.36 | 49 |
76908 | Male | 34 | 2.12 | 97 |
414394 | Male | 34 | 0.17 | 42 |
80144 | Male | 35 | 0.53 | 108 |
474914 | Male | 44 | 34.65 | 91 |
267849 | Male | 34 | 263.82 | 126 |
103232 | Male | 34 | 338.72 | 121 |
271387 | Female | 30 | 490.31 | 167 |
495742 | Male | 32 | 59.31 | 91 |
243776 | Female | 33 | 82.9 | 147 |
56338 | Male | 34 | 550.0 | 77 |